It is a pharma private limited company based in New Delhi, Delhi, India, established in 2013.
2013 | New Delhi, Delhi, India | ActiveGrandeur Pharma Private Limited, a active private limited company, was established on 05 March 2013 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239DL2013PTC249057. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹7.50 M.
It upholds a compliant status. Its leadership includes Dhairya Ramchandani (Director), Kushagra Ramchandani (Director). Past directors included Duiti Ramchandani, Kushagra Ramchandani. It holds ₹3.51 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 47/1, Lower Ground Floor East Patel Nagar, New Delhi, Delhi, 110060.
U24239DL2013PTC249057
249057
05 March 2013
₹1.00 Cr
₹7.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Grandeur Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhairya Ramchandani | Director | 05 Mar 2013 | Current |
| Kushagra Ramchandani | Director | 02 Nov 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Jul 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Grandeur Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.79% increase. The company also saw a substantial improvement in profitability, with a 23.36% increase in profit. The company's net worth Soared by an impressive increase of 23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Grandeur Pharma had a public holding of 19.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹35,050,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jul 2020 | Others | ₹4.80 M | Open |
| 27 Apr 2020 | Others | ₹2.75 M | Open |
| 10 Oct 2017 | Others | ₹2.75 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Grandeur Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Grandeur Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grandeur Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Grandeur Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Grandeur Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity A charge with Others amounted to Rs. 0.48 Cr with Charge ID 100369362 was registered on 06 Jul 2020. was completed.
The activity A charge with Others amounted to Rs. 0.28 Cr with Charge ID 100369361 was registered on 27 Apr 2020. was completed.
Progress on A charge with Others of Rs. 2.75 Cr registered on 10 Oct 2017 with Charge ID 100166230 was modified on 02 Jan 2019. was documented.
The activity A charge with Others amounted to Rs. 2.75 Cr with Charge ID 100166230 was registered on 10 Oct 2017. was completed.
The CIN of Grandeur Pharma Private Limited is U24239DL2013PTC249057.
Grandeur Pharma Private Limited is headquartered at 47/1, Lower Ground Floor East Patel Nagar, New Delhi, Delhi, 110060.
Grandeur Pharma Private Limited was incorporated on 05 March 2013.
The current directors of Grandeur Pharma Private Limited are
The primary industry of Grandeur Pharma Private Limited is Trade.
Grandeur Pharma Private Limited is unlisted.
The authorized capital of Grandeur Pharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹7.50 M.
The compliance status of Grandeur Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX